Authors:
Olivieri, I
Brandi, G
Padula, A
Di Stefano, M
Mantovani, W
Calabrese, C
Saccoccio, G
Di Febo, G
Corazza, GR
Miglioli, M
Biasco, G
Citation: I. Olivieri et al., Lack of association with spondyloarthritis and HLA-B27 in Italian patientswith Whipple's disease, J RHEUMATOL, 28(6), 2001, pp. 1294-1297
Authors:
Cardin, R
Saccoccio, G
Masutti, F
Bellentani, S
Farinati, F
Tiribelli, C
Citation: R. Cardin et al., DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study, J HEPATOL, 34(4), 2001, pp. 587-592
Authors:
Bellentani, S
Miglioli, L
Masutti, F
Saccoccio, G
Tiribelli, C
Citation: S. Bellentani et al., Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery, MICROBES IN, 2(14), 2000, pp. 1757-1763
Authors:
Almasio, PL
Floreani, A
Chiaramonte, M
Provenzano, G
Battezzati, P
Crosignani, A
Podda, M
Todros, L
Rosina, F
Saccoccio, G
Manenti, F
Ballardini, G
Bianchi, FP
Scheuer, PJ
Davies, SE
Craxi, A
Citation: Pl. Almasio et al., Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis, ALIM PHARM, 14(12), 2000, pp. 1645-1652
Authors:
Lenzi, M
Bellentani, S
Saccoccio, G
Muratori, P
Masutti, F
Muratori, L
Cassani, F
Bianchi, FB
Tiribelli, C
Citation: M. Lenzi et al., Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort, GUT, 45(3), 1999, pp. 435-441
Authors:
Bellentani, S
Pozzato, G
Saccoccio, G
Crovatto, M
Croce, LS
Mazzoran, L
Masutti, F
Cristianini, G
Tiribelli, C
Citation: S. Bellentani et al., Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study, GUT, 44(6), 1999, pp. 874-880